Last year, a (much disputed) paper generated headlines by suggesting there was a lack of evidence for some orthopaedic surgery. Now, a new paper suggests quite the contrary.

Around 5%-10% of hamstring grafts used in ACL reconstruction fail each year. When that happens, isn’t repeating the process with another hamstring simply risking the same outcome? And new research confirms the value of an alternative approach.

Yorkshire Knee Clinic looks at the current state of knee replacement waiting lists in the private sector and in Mid Yorkshire Hospitals Trust.

YKC’s Nick London reveals research that shows partial knee replacements are now suitable for “a majority of patients”.

We know that for the under 50s and the elderly, total knee replacements can present challenges. But what’s the position with partial knee replacements?

Nick London discusses his latest research and what it means for patients who need a partial knee replacement, but also have kneecap arthritis.

YKC’s Nick London and Dave Duffy have been researching whether the lack of an anterior cruciate ligament causes problems for partial knee replacement patients.

The NHS is a major source of C02, with emissions often ‘baked in’ to the products and equipment it uses and the processes it operates. So what’s being done to make things better? Dave Duffy explains.

Is my knee replacement guaranteed? What happens if there’s an issue with your knee implant? Dave Duffy explains.

If you need a knee replacement in middle age, what’s the problem?

Waiting for a knee replacement? We offer an update on NHS and private waiting times.

YKC’s Jim Newman explains why, following long months of lockdown, knee surgery has become more demanding.

What happens if your knee replacement reaches the end of its working life? Jim Newman explains.

You may have worn it. You’ll almost certainly have seen athletes using it. But what does kinesio tape do? Jim Newman explains.

Waiting lists are one major area of concern for the NHS. But lists alone don’t tell the whole story of the challenge we face, says Jim Newman.